Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4UB6
|
||||
| Drug Name |
[(3-Bromophenyl)-(2,4-ditrifluoromethylphenyl)-ketone]thiosemicarbazone
|
||||
| Synonyms |
CHEMBL603084
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H10BrF6N3S
|
||||
| Canonical SMILES |
NC(=S)N\\N=C(\\c1cccc(Br)c1)/c2cc(cc(c2)C(F)(F)F)C(F)(F)F
|
||||
| InChI |
InChI=1S/C16H10BrF6N3S/c17-12-3-1-2-8(6-12)13(25-26-14(24)27)9-4-10(15(18,19)20)7-11(5-9)16(21,22)23/h1-7H,(H3,24,26,27)/b25-13-
|
||||
| InChIKey |
UEJPFCHOVUNXKX-MXAYSNPKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.